Porcine Liver Tissue (Sus scrofa domesticus)

Porcine liver tissue supplement contains hepatocyte growth factor (HGF) at 1.07 µg/mg and extracellular matrix components like collagen. Current research focuses primarily on bioengineering applications rather than established health benefits in humans.

Origin & History

Porcine liver tissue derives from the liver of Sus scrofa domesticus (domestic pig), typically sourced from slaughterhouse animals or surgical byproducts. Processing involves clamping and severing vascular structures, followed by decellularization or solubilization to create scaffolds or matrices containing collagens, proteoglycans, fibronectin, and growth factors.

Historical & Cultural Context

No evidence of historical or traditional medicinal use of porcine liver tissue appears in available research. Current applications focus exclusively on modern biomedical uses like tissue engineering and preclinical modeling.

Health Benefits

• No clinical evidence exists for health benefits as a supplement - all research focuses on bioengineering applications
• Contains hepatocyte growth factor (HGF at 1.07 µg/mg) and other growth factors in processed forms - preliminary evidence only
• Preserves extracellular matrix components like collagen I/IV and fibronectin - in vitro studies only
• Supports hepatocyte function in laboratory settings - no human trials
• Shows low immunogenicity in decellularized form - based on animal model studies only

How It Works

Hepatocyte growth factor (HGF) in porcine liver tissue activates the c-Met receptor pathway, potentially promoting cellular regeneration and tissue repair. The preserved extracellular matrix components, including collagen and fibronectin, may support structural tissue integrity. However, bioavailability and activity of these compounds when consumed orally remains unclear.

Scientific Research

No human clinical trials, RCTs, or meta-analyses were identified for porcine liver tissue as a supplement or therapeutic. All available research focuses exclusively on preclinical porcine models, ex vivo perfusion platforms, or bioengineering scaffolds for liver research.

Clinical Summary

No clinical trials have evaluated porcine liver tissue as a dietary supplement for health benefits. Current research focuses exclusively on bioengineering applications, such as tissue scaffolding and regenerative medicine. Biochemical analysis confirms HGF content at 1.07 µg/mg in processed forms, but human supplementation studies are absent. Evidence for health benefits remains preliminary and limited to in vitro characterization of bioactive compounds.

Nutritional Profile

Porcine liver tissue (Sus scrofa domesticus) in its whole food form contains approximately 26g protein per 100g wet weight, with a complete essential amino acid profile including lysine (~2.2g/100g), leucine (~2.1g/100g), and threonine (~1.1g/100g). Fat content is low at ~3.6g/100g, predominantly phospholipids and polyunsaturated fatty acids. Carbohydrate content is minimal (~3.8g/100g, primarily glycogen). As a micronutrient source, raw porcine liver is exceptionally rich in vitamin A (retinol, ~6,500 µg RAE/100g), vitamin B12 (~26 µg/100g, >1,000% DV), riboflavin B2 (~3.0 mg/100g), folate (~145 µg/100g), heme iron (~18 mg/100g with ~25-35% bioavailability), zinc (~4mg/100g), copper (~6mg/100g), and selenium (~30 µg/100g). Bioactive compounds include coenzyme Q10 (~35mg/100g), carnitine (~90mg/100g), taurine (~50mg/100g), and glutathione (~30mg/100g). In decellularized/processed scaffold form (as used in bioengineering applications), most water-soluble vitamins and small molecules are removed or degraded during processing; what is predominantly retained is the extracellular matrix protein fraction: collagen type I/IV, laminin, fibronectin, and glycosaminoglycans (~15-20 µg/mg dry weight total). Growth factors including HGF (~1.07 µg/mg), EGF, and TGF-β persist in measurable quantities post-processing but bioavailability via oral/supplemental routes is expected to be negligible due to gastrointestinal proteolysis.

Preparation & Dosage

No clinically studied dosage ranges or standardized forms are available, as no studies evaluate porcine liver tissue as an oral or supplemental agent. Research only describes tissue procurement methods for bioengineering purposes. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic combinations studied, milk thistle, NAC, alpha-lipoic acid, vitamin B complex

Safety & Interactions

Safety data for porcine liver tissue supplements is limited due to lack of human studies. Potential risks include allergic reactions to porcine proteins and contamination concerns if sourcing is inadequate. No known drug interactions have been documented, though growth factors could theoretically interact with medications affecting cellular proliferation. Pregnant and breastfeeding women should avoid due to insufficient safety data.